Endurant Capital Management’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-43,542	Closed	-$1.26M	–	76
2021 Q4	$1.26M	Buy	+43,542	New	+$1.26M	0.3%	50